Status:

COMPLETED

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Lead Sponsor:

Northside Hospital, Inc.

Collaborating Sponsors:

Blood and Marrow Transplant Group of Georgia

Conditions:

Chronic Graft-versus-host Disease

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Rituximab is an attractive agent to bring to the upfront treatment of chronic graft-versus-host disease (cGVHD) due to its favorable toxicity profile, its proven efficacy in the treatment of steroid-r...

Detailed Description

Although allogeneic hematopoietic stem cell transplantation (HSCT) remains an important curative therapy for many patients with hematological malignancies, treatment-related morbidity and mortality co...

Eligibility Criteria

Inclusion

  • First episode of extensive chronic GvHD, without residual or concurrent acute GvHD.
  • Age 18 - 75
  • Any primary diagnosis requiring treatment by allogeneic HSCT
  • Recipient of an allogeneic stem cell transplant (bone marrow, peripheral blood stem cell, or cord blood) from a related or unrelated donor, minimum 80 days ago
  • Conditioning regimen: Myeloablative or non-myeloablative
  • Patient gives written informed consent

Exclusion

  • Creatinine \> 2.0 mg/dl
  • Uncontrolled, active infection
  • Recurrent or progressive malignancy
  • Anticipated life expectancy of less than 1 year
  • Pregnant or breast feeding
  • Contraindications to administration of the study intervention or known inability of the patient to tolerate the study intervention
  • Patients with perceived fixed, irreversible defects (pulmonary involvement, contractures, etc.) which would not be expected to improve with the study intervention
  • Residual or concurrent acute GVHD

Key Trial Info

Start Date :

April 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT01161628

Start Date

April 1 2011

End Date

July 1 2015

Last Update

April 20 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northside Hospital

Atlanta, Georgia, United States, 30342